Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-26 @ 2:34 AM
Study NCT ID:
NCT07042802
Status:
RECRUITING
Last Update Posted:
2025-12-02
First Post:
2025-06-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer
Sponsor:
Nanjing Leads Biolabs Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-25
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-17
First Submit QC Date:
None
Study First Post Date:
2025-06-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-29
Last Update Post Date:
2025-12-02
Last Update Post Date Type:
ESTIMATED